Zhou C, et al. - Researchers analyzed studies reporting the links between statin use and survival outcomes for esophageal cancer patients, via this systematic review and meta-analysis. They analyzed five cohort studies involving 24,576 patients. They found that improved overall survival and disease-free survival were reported in relation to statin use in esophageal cancer patients. In the esophageal adenocarcinoma subgroup and the esophageal squamous cell cancer subgroup, they reported improved survival outcomes were consistent. Overall, findings showed a potential therapeutic role of statins in esophageal cancer.